Together with the upregulation of MALAT1 in both cell lines and clinical tissue samples, the authors observed that patients with high expression level of MALAT1 had a significantly increased risk of tumor recurrence after liver transplantation. The gene discussed is MALAT1; the disease is neoplasm.